Synairgen Share Price | |
---|---|
Price | 6.20 |
Bid | 5.52 |
Ask | 7.00 |
Change | 0.08 (1.31%) |
Volume | 84,000 |
Open | 6.20 |
High | 6.20 |
Low | 6.20 |
Prev. Close | 6.12 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 201.37m |
Market Capitalisation | £12.49m |
Market Size | 30,000 |
52 Week High | 10.62 |
52 Week High Date | 29-Nov-2023 |
52 Week Low | 4.20 |
52 Week Low Date | 22-Mar-2024 |
# Trades | 18 |
---|---|
Vol. Sold | 49,679 |
Sold Value | £3.02k |
Vol. Bought | 34,321 |
Bought Value | £2.16k |
PE Ratio | -0.707763 |
Earnings | -8.76 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
03-May-24 | 16:35:23 | 6.20 | 178 | Buy* | 5.52 | 7.00 | 11.04 | UT Uncrossing Trade |
03-May-24 | 14:35:11 | 5.91 | 600 | Sell* | 5.52 | 7.00 | 35.46 | O Ordinary |
03-May-24 | 14:34:56 | 5.865 | 900 | Sell* | 5.52 | 7.00 | 52.79 | O Ordinary |
03-May-24 | 14:34:40 | 5.91 | 500 | Sell* | 5.52 | 7.00 | 29.55 | O Ordinary |
03-May-24 | 14:30:08 | 6.26 | 31,885 | Buy* | 5.52 | 7.00 | 1,996 | O Ordinary |
03-May-24 | 14:27:11 | 5.91 | 561 | Sell* | 5.52 | 7.00 | 33.16 | O Ordinary |
03-May-24 | 12:58:49 | 5.91 | 6,274 | Sell* | 5.52 | 7.00 | 370.79 | O Ordinary |
03-May-24 | 12:43:32 | 5.865 | 1,201 | Sell* | 5.52 | 7.00 | 70.44 | O Ordinary |
03-May-24 | 12:29:43 | 6.852 | 258 | Buy* | 5.52 | 7.00 | 17.68 | O Ordinary |
03-May-24 | 08:41:14 | 6.20 | 1,493 | Sell* | 6.20 | 7.00 | 92.57 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
28-Jan-22 | 27-Jan-22 | Buy | Bruce Campbell held the position of Non-Executive Director at the time of this trade.Bruce Campbell | 189.42 | GBX | 621 | 8,520 |
28-Jan-22 | 27-Jan-22 | Buy | Bruce Campbell held the position of Non-Executive Director at the time of this trade.Bruce Campbell | 189.74 | GBX | 7,899 | 8,520 |
12-Aug-21 | 12-Aug-21 | Exercise of Option | John C Ward held the position of Finance Director at the time of this trade.John C Ward | 1.00 | GBX | 489,148 | 734,092 |
12-Aug-21 | 12-Aug-21 | Sell | Phillip David Monk held the position of Chief Scientific Officer at the time of this trade.Phillip David Monk | 140.00 | GBX | 220,878 | 423,934 |
12-Aug-21 | 12-Aug-21 | Exercise of Option | Phillip David Monk held the position of Chief Scientific Officer at the time of this trade.Phillip David Monk | 1.00 | GBX | 400,212 | 423,934 |
Synairgen is a drug discovery and development company founded to combat severe respiratory diseases. Discover SNG001, our breakthrough treatment for COVID-19.